Clinical Trials

22 video summaries

Build a research pod on Clinical Trials.

22 videos curated. Save them to your own pod, ask any question across the body of expert opinion, and connect it to Claude or ChatGPT.

Get Started Free

Videos About Clinical Trials

357 ‒ A new era of longevity science: models of aging, rapamycin trials, biological clocks, & more

357 ‒ A new era of longevity science: models of aging, rapamycin trials, biological clocks, & more

Peter Attia MD

#137 - Paul Offit, M.D.: An expert perspective on COVID-19 vaccines

#137 - Paul Offit, M.D.: An expert perspective on COVID-19 vaccines

Peter Attia MD

The Science of Psychedelics for Mental Health | Dr. Robin Carhart-Harris

The Science of Psychedelics for Mental Health | Dr. Robin Carhart-Harris

Andrew Huberman

"Anti-Aging" Drugs — NAD, metformin, & rapamycin | The Peter Attia Drive Podcast (Ep 207, AMA 35)

"Anti-Aging" Drugs — NAD, metformin, & rapamycin | The Peter Attia Drive Podcast (Ep 207, AMA 35)

Peter Attia MD

The Future of Psychedelic Medicine: A Conversation with Jeannie Fontana and Robin Carhart-Harris

The Future of Psychedelic Medicine: A Conversation with Jeannie Fontana and Robin Carhart-Harris

Sam Harris

204 - Centenarians, metformin, and longevity | Nir Barzilai, M.D.

204 - Centenarians, metformin, and longevity | Nir Barzilai, M.D.

Peter Attia MD

175 - The biology of aging, rapamycin, and other interventions that target the aging process

175 - The biology of aging, rapamycin, and other interventions that target the aging process

Peter Attia MD

230 ‒ Cardiovascular disease in women: prevention, risk factors, lipids, and more

230 ‒ Cardiovascular disease in women: prevention, risk factors, lipids, and more

Peter Attia MD

John Abramson: Big Pharma | Lex Fridman Podcast #263

John Abramson: Big Pharma | Lex Fridman Podcast #263

Lex Fridman

164 - Diagnosing, preventing, & treating Alzheimer’s disease, & life lessons from dementia patients

164 - Diagnosing, preventing, & treating Alzheimer’s disease, & life lessons from dementia patients

Peter Attia MD

Albert Bourla: Pfizer CEO | Lex Fridman Podcast #249

Albert Bourla: Pfizer CEO | Lex Fridman Podcast #249

Lex Fridman

The Causes & Treatments for Autism | Dr. Karen Parker

The Causes & Treatments for Autism | Dr. Karen Parker

Andrew Huberman

#143 - John Ioannidis, M.D., D.Sc.: Why most biomedical research is flawed, and how to improve it

#143 - John Ioannidis, M.D., D.Sc.: Why most biomedical research is flawed, and how to improve it

Peter Attia MD

188 - [AMA #30 Sneak Peek] How to Read and Understand Scientific Studies

188 - [AMA #30 Sneak Peek] How to Read and Understand Scientific Studies

Peter Attia MD

The Possibilities of Mind-Altering Compounds | Dr. Suresh Muthukumaraswamy | The Tim Ferriss Show

The Possibilities of Mind-Altering Compounds | Dr. Suresh Muthukumaraswamy | The Tim Ferriss Show

Tim Ferriss

#133 - Vinay Prasad, M.D., M.P.H: Hallmarks of successful cancer policy

#133 - Vinay Prasad, M.D., M.P.H: Hallmarks of successful cancer policy

Peter Attia MD

#123–Joan Mannick & Nir Barzilai: Rapamycin and metformin—longevity, immune enhancement, & COVID-19

#123–Joan Mannick & Nir Barzilai: Rapamycin and metformin—longevity, immune enhancement, & COVID-19

Peter Attia MD

#118 – Lloyd Klickstein, M.D., Ph.D.: Rapamycin, mTOR inhibition, and the biology of aging

#118 – Lloyd Klickstein, M.D., Ph.D.: Rapamycin, mTOR inhibition, and the biology of aging

Peter Attia MD

Researching Psilocybin's Effects on Depression - Dr. Rosalind Watts

Researching Psilocybin's Effects on Depression - Dr. Rosalind Watts

Y Combinator

#65–Rick Doblin, PhD: MDMA—creation, scheduling, toxicity, therapeutic use & changing public opinion

#65–Rick Doblin, PhD: MDMA—creation, scheduling, toxicity, therapeutic use & changing public opinion

Peter Attia MD

Rick Doblin — Psychedelic Breakthroughs, $10M Bets, PTSD Promise, and More | The Tim Ferriss Show

Rick Doblin — Psychedelic Breakthroughs, $10M Bets, PTSD Promise, and More | The Tim Ferriss Show

Tim Ferriss

220 ‒ Ketamine: Benefits, risks, and promising therapeutic potential | Celia Morgan, Ph.D.

220 ‒ Ketamine: Benefits, risks, and promising therapeutic potential | Celia Morgan, Ph.D.

Peter Attia MD